Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT05521438
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeNCT05521438 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Active not recruiting | 2025-12-30Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |